TAPI 1
CAS: 163847-77-6
Ref. 3D-NGA84777
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado |
Informação sobre produto
Nome:
TAPI 1
Sinónimos:
- L-Alaninamide, N-[(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-(2-naphthalenyl)-L-alanyl-N-(2-aminoethyl)-
- L-Alaninamide, N-[2-[2-(hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-(2-naphthalenyl)-L-alanyl-N-(2-aminoethyl)-, (R)-
- TNF-a protease inhibitor 1
- N-[(2R)-2-[2-(Hydroxyamino)-2-oxoethyl]-4-methyl-1-oxopentyl]-3-(2-naphthalenyl)-L-alanyl-N-(2-aminoethyl)-L-alaninamide
Descrição:
TAPI 1 is a protein-based drug that inhibits the activity of epidermal growth factor receptor (EGFR). TAPI 1 binds to EGFR and prevents its activation by binding to the extracellular domain. This inhibition leads to an increase in apoptosis of cancer cells, such as those found in carcinoma cell lines. TAPI 1 also inhibits HIV infection, which may be due to its ability to inhibit the expression of neurokinin-1 receptor, which is involved in viral replication and signaling.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
499.6 g/mol
Fórmula:
C26H37N5O5
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
